✦ LIBER ✦

PIN79 Cost-Utility Analysis of Tenofovir in Comparison with Other Nucleoside Analogues (AN) in Chronic Hepatitis B (CHB) Treatment

✍ Scribed by B. Gwiosda; J. Krzystek; G. Niesyczynski; K. Osiewalski; P. Mierzejewski; M. Kazmierski; M. Wladysiuk; R. Plisko

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cost Effectiveness Analysis Of Tenofovir

✍ Soto, H.; Botello, B.S.; Pizarro, M.; Rizzoli, A.; Gozález, L.A. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 72 KB

Cost–Utility Analysis of Tenofovir Disop

✍ Helen Dakin; Anthony Bentley; Geoff Dusheiko 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 317 KB

PIN18 COST-UTILITY ANALYSIS OF TREATMENT

✍ X Sun; Y Li; L Zhao 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 72 KB

559 COST-EFFECTIVENESS SIMULATION ANALYS

✍ B. Deniz; F. Everhard 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 54 KB

PIN2 Safety and Efficacy of Tenofovir as

✍ P. Wojciechowski; A. Stozek; J. Szmyd; B. Gwiosda; P. Mierzejewski; M. Kazmiersk 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 57 KB

558 COST-EFFECTIVENESS SIMULATION ANALYS

✍ B. Deniz; M. Buti; M. Brosa; M.A. Casado; M. Rueda; F. Everhard; R. Esteban 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 50 KB